ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683125 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683125; 2) Community: the network communities that were significantly associated with the response to NSC 683125; 3) Molecule: the relationships between components within communities and NSC 683125; 4) MDR: the compounds that were significantly associated with the NSC 683125.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0342636096654271 0.30166821
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0342636096654271 0.227195
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0342636096654271 0.17500288
NSC 104942 EUPAROTIN 0.0342636096654276 0.23351287
NSC 119875 Cisplatin 0.0342636096654276 0.30800689
NSC 121713 Null 0.0342636096654276 0.48494052
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0342636096654276 0.19701517
NSC 185057 Acetic acid, phenoxy-, 6-[[(aminothioxomethyl)hydrazono]methyl]-3-pyridinyl ester 0.0342636096654276 0.4018317
NSC 274553 Null 0.0342636096654276 0.1934055
NSC 306911 .beta.-D-Glucopyranose, 2,3-O-(diethylstannylene)- 0.0342636096654276 -0.032675856
Total:85  Current:62    [First] [Prev] [Next] [Last]